1
|
Rutter M. Transitions and Turning Points in Developmental Psychopathology: As applied to the Age Span between Childhood and Mid-adulthood. INTERNATIONAL JOURNAL OF BEHAVIORAL DEVELOPMENT 2016. [DOI: 10.1177/016502549601900309] [Citation(s) in RCA: 218] [Impact Index Per Article: 27.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
In recent years, several studies have produced data showing apparent changes in early adult life of psychological life trajectories, changes that have been labelled "turning points". The concept, and the phenomena that gave rise to it, are critically reviewed in relation to developmental psychopathology. It is concluded that a wide range of experiences have been associated with such changes; that the experiences associated with them span those over which the individual has no control and those subject to individual choice and actions; that the key features associated with change usually involve particular qualities of experiences as they impinge on subsegments of the population (rather than universal life phase transitions); that the experiences are not synonymous with stressful life events; and that changes in life trajectory may reflect genetic programming or internal biological alterations rather than external happenings. Also, major life experiences may accentuate, rather than alter, individual characteristics. It is concluded that turning point effects represent a heterogeneous range of lasting changes in psychological functioning. They are important because their investigation may shed important light on developmental processes. They do not represent a simple mechanism and hence there is no hypothesis about a particular process to test, but their study is nevertheless crucial for an understanding of developmental continuities and discontinuities. Some of the key methodological issues in their investigation are reviewed.
Collapse
Affiliation(s)
- Michael Rutter
- MRC Child Psychiatry Unit and Centre for Social, Genetic and
Developmental Psychiatry, London, UK
| |
Collapse
|
2
|
Plotnin R, Rutter M. Child Development, Molecular Genetics, and What to Do with Genes Once They Are Found. Child Dev 2008. [DOI: 10.1111/j.1467-8624.1998.tb06169.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
3
|
Rutter M, Moffitt TE, Caspi A. Gene-environment interplay and psychopathology: multiple varieties but real effects. J Child Psychol Psychiatry 2006; 47:226-61. [PMID: 16492258 DOI: 10.1111/j.1469-7610.2005.01557.x] [Citation(s) in RCA: 534] [Impact Index Per Article: 29.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Gene-environment interplay is a general term that covers several divergent concepts with different meanings and different implications. In this review, we evaluate research evidence on four varieties of gene-environment interplay. First, we consider epigenetic mechanisms by which environmental influences alter the effects of genes. Second, we focus on variations in heritability according to environmental circumstances. Third, we discuss what is known about gene-environment correlations. Finally, we assess concepts and findings on the interaction between specific identified genes and specific measured environmental risks. In order to provide an understanding of what may be involved in gene-environment interplay, we begin our presentation with a brief historical review of prevailing views about the role of genetic and environmental factors in the causation of mental disorders, and we provide a simplified account of some of the key features of how genes 'work'.
Collapse
|
4
|
Liu J, Juo SH, Dewan A, Grunn A, Tong X, Brito M, Park N, Loth JE, Kanyas K, Lerer B, Endicott J, Penchaszadeh G, Knowles JA, Ott J, Gilliam TC, Baron M. Evidence for a putative bipolar disorder locus on 2p13-16 and other potential loci on 4q31, 7q34, 8q13, 9q31, 10q21-24, 13q32, 14q21 and 17q11-12. Mol Psychiatry 2003; 8:333-42. [PMID: 12660806 DOI: 10.1038/sj.mp.4001254] [Citation(s) in RCA: 91] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Abstract
Bipolar disorder (BP) is a severe and common psychiatric disorder characterized by extreme mood swings. Family, twin and adoption studies strongly support a genetic component. The mode of inheritance is complex and likely involves multiple, as yet unidentified genes. To identify susceptibility loci, we conducted a genome-wide scan with 343 microsatellite markers in one of the largest, well-characterized pedigree samples assembled to date (373 individuals in 40 pedigrees). To increase power to detect linkage, scan statistics were used to examine the logarithm of odds (lod) scores based on evidence at adjacent chromosomal loci. This analysis yielded significant evidence of linkage (genome-wide P&<0.05) for markers on 2p13-16. Standard linkage analysis was also supportive of linkage to 2p13-16 (lod=3.20), and identified several other interesting regions: 4q31 (lod=3.16), 7q34 (lod=2.78), 8q13 (lod=2.06), 9q31 (lod=2.07), 10q24 (lod=2.79), 13q32 (lod=2.2), 14q21 (lod=2.36) and 17q11-12 (lod=2.75). In this systematic, large-scale study, we identified novel putative loci for BP (on 2p13-16, 8q13 and 14q21) and found support for previously proposed loci (on 4q31, 7q34, 9q31, 10q21-24, 13q32 and 17q11-12). Two of the regions implicated in our study, 2p13-14 and 13q32, have also been linked to schizophrenia, suggesting that the two disorders may have susceptibility genes in common.
Collapse
MESH Headings
- Adolescent
- Adult
- Bipolar Disorder/genetics
- Chromosomes, Human, Pair 10
- Chromosomes, Human, Pair 13
- Chromosomes, Human, Pair 14
- Chromosomes, Human, Pair 17
- Chromosomes, Human, Pair 2
- Chromosomes, Human, Pair 4
- Chromosomes, Human, Pair 7
- Chromosomes, Human, Pair 8
- Chromosomes, Human, Pair 9
- Genetic Predisposition to Disease/genetics
- Humans
- Lod Score
Collapse
Affiliation(s)
- J Liu
- Columbia Genome Center and Department o fPsychiatry, Columbia University , New York, NY 10032, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Baron M. Manic-depression genes and the new millennium: poised for discovery. Mol Psychiatry 2002; 7:342-58. [PMID: 11986978 DOI: 10.1038/sj.mp.4000998] [Citation(s) in RCA: 75] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/06/2001] [Revised: 08/02/2001] [Accepted: 08/08/2001] [Indexed: 12/29/2022]
Abstract
Manic-depressive illness is a common psychiatric disorder with complex etiology that likely involves multiple genes and non-genetic influences. The uncertain path to gene discovery has spurred considerable debate over genetic findings and gene-finding strategies. In this article, I review the main findings, with a focus on: (1) putative linked loci on chromosomes 1q31-32, 4p16, 6pter-p24, 10p14, 10q21-26, 12q23-24, 13q31-32, 18p11, 18q21-23, 21q22, 22q11-13, and Xq24-28; and (2) association studies with candidate genes, dynamic mutations, mitochondrial mutations, and chromosomal aberrations. Although no gene has been identified, promising findings are emerging. I then discuss the challenges and opportunities ahead, with special emphasis on gene-finding methods-in particular, questions pertaining to phenotype definition, linkage and association mapping, gene markers, sampling, study population, multigene systems, lessons from other disorders, animal models, and bioinformatics. The progress to date, together with rapid advances in genomics, analytical and computational methods, and bioinformatics, holds promise for new insights into the genetics of manic-depression, in the new millennium.
Collapse
Affiliation(s)
- M Baron
- Department of Psychiatry, Columbia University College of Physicians and Surgeons and Department of Medical Genetics, New York State Psychiatric Institute, New York 10032, USA.
| |
Collapse
|
6
|
Feusner J, Ritchie T, Lawford B, Young RM, Kann B, Noble EP. GABA(A) receptor beta 3 subunit gene and psychiatric morbidity in a post-traumatic stress disorder population. Psychiatry Res 2001; 104:109-17. [PMID: 11711165 DOI: 10.1016/s0165-1781(01)00296-7] [Citation(s) in RCA: 52] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
GABAergic systems have been implicated in the pathogenesis of anxiety, depression and insomnia. These symptoms are part of the core and comorbid psychiatric disturbances in post-traumatic stress disorder (PTSD). In a sample of Caucasian male PTSD patients, dinucleotide repeat polymorphisms of the GABA(A) receptor beta 3 subunit gene were compared to scores on the General Health Questionnaire-28 (GHQ). As the major allele at this gene locus (GABRB3) was G1, the alleles were divided into G1 and non-G1 groups. On the total score of the GHQ, which comprises the somatic symptoms, anxiety/insomnia, social dysfunction and depression subscales, patients with the G1 non-G1 genotype had a significantly higher score when compared to either the G1G1 genotype (alpha=0.01) or the non-G1 non-G1 genotype (alpha=0.05). No significant difference was found between the G1G1 and non-G1 non-G1 genotypes. When the G1 non-G1 heterozygotes were compared to the combined G1G1 and non-G1 non-G1 homozygotes, a significantly higher total GHQ score was found in the heterozygotes (P=0.002). These observations suggest a heterosis effect. Further analysis of GHQ subscale scores showed that heterozygotes compared to the combined homozygotes had higher scores on the somatic symptoms (P=0.006), anxiety/insomnia (P=0.003), social dysfunction (P=0.054) and depression (P=0.004) subscales. In conclusion, the present study indicates that in a population of PTSD patients, heterozygosity of the GABRB3 major (G1) allele confers higher levels of somatic symptoms, anxiety/insomnia, social dysfunction and depression than found in homozygosity.
Collapse
Affiliation(s)
- J Feusner
- Alcohol Research Center and Department of Psychiatry and Biobehavioral Sciences, UCLA Neuropsychiatric Institute, 760 Westwood Plaza, Los Angeles, CA 90024-1759, USA
| | | | | | | | | | | |
Collapse
|
7
|
Abstract
Reviewers in the 1960s and early 1970s were skeptical about any substantial role for genetic factors in the etiology of autism. A realization that the 2% rate of autism in siblings (as estimated at that time) was far above the general population base rate, and that this suggested a possible high genetic liability, led to the first small-scale twin study of autism. The replicated evidence from both twin and family studies undertaken in the 1970s and 1980s indicated both strong genetic influences and the likelihood that they applied to a phenotype that was much broader than the traditional diagnostic category of autism. Medical and chromosomal findings also indicated genetic heterogeneity. Advances in molecular genetics led to genome-wide scans of affected relative pair samples with a positive log of the odds to base 10 score for a location on chromosome 7. The major remaining research challenges and the likely clinical benefits that should derive from genetic research are considered in relation to both current knowledge and that anticipated to emerge from research over the next decade.
Collapse
Affiliation(s)
- M Rutter
- Social, Genetic, and Developmental Psychiatry Research Centre, Institute of Psychiatry, London, UK.
| |
Collapse
|
8
|
|
9
|
Brzustowicz LM, Honer WG, Chow EW, Hogan J, Hodgkinson K, Bassett AS. Use of a quantitative trait to map a locus associated with severity of positive symptoms in familial schizophrenia to chromosome 6p. Am J Hum Genet 1997; 61:1388-96. [PMID: 9399881 PMCID: PMC1716068 DOI: 10.1086/301623] [Citation(s) in RCA: 51] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
A number of recent linkage studies have suggested the presence of a schizophrenia susceptibility locus on chromosome 6p. We evaluated 28 genetic markers, spanning chromosome 6, for linkage to schizophrenia in 10 moderately large Canadian families of Celtic ancestry. Parametric analyses of these families under autosomal dominant and recessive models, using broad and narrow definitions of schizophrenia, produced no significant evidence for linkage. A sib-pair analysis using categorical disease definitions also failed to produce significant evidence for linkage. We then conducted a separate sibpair analysis using scores on positive-symptom (psychotic), negative-symptom (deficit), and general psychopathology-symptom scales as quantitative traits. With the positive symptom-scale scores, the marker D6S1960 produced P = 1.2 x 10(-5) under two-point and P = 5.4 x 10(-6) under multipoint analyses. Using simulation studies, we determined that these nominal P values correspond to empirical P values of .034 and .0085, respectively. These results suggest that a schizophrenia susceptibility locus on chromosome 6p may be related to the severity of psychotic symptoms. Assessment of behavioral quantitative traits may provide increased power over categorical phenotype assignment for detection of linkage in complex psychiatric disorders.
Collapse
Affiliation(s)
- L M Brzustowicz
- Center for Molecular and Behavioral Neuroscience, Rutgers University, Newark, NJ 07102, USA.
| | | | | | | | | | | |
Collapse
|
10
|
Abstract
BACKGROUND The opportunities for psychiatry deriving from available or likely genetic advances are reviewed. METHOD Clinical implications are considered in the context of both the misconceptions and benefits associated with relevant genetic findings. RESULTS Misconceptions include that: heritability estimates have a 'true' fixed value; a high heritability means that environmental interventions will be ineffective; a high heritability within groups means that differences between groups will also be due to genes; genetic effects are determinative; 'genetic' means single abnormal genes; genes associated with disease must be bad and justify eugenic measures; gene therapy will be widely applicable; and genetic screening of the general population will be useful. The benefits include demonstrations that: both genes and environment have an ubiquitous influence; some prevailing diagnostic assumptions are mistaken; genes influence development; the effects of nature and nurture are not separate; and environmental effects tend to be person-specific. The potential value of molecular genetics lies in elucidation of causal processes as they apply to both brain systems and nature-nurture interplay; improving diagnosis and genetic counselling; and the development of improved pharmacological interventions. CONCLUSION Advances in genetics will make a major impact on clinical psychiatry, and should bring practical benefits for both prevention and treatment.
Collapse
Affiliation(s)
- M Rutter
- MRC Child Psychiatry Unit, Institute of Psychiatry, London
| | | |
Collapse
|
11
|
Rutter M. Implications of genetic research for child psychiatry. CANADIAN JOURNAL OF PSYCHIATRY. REVUE CANADIENNE DE PSYCHIATRIE 1997; 42:569-76. [PMID: 9288418 DOI: 10.1177/070674379704200602] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
OBJECTIVE To review implications of genetic research in child psychiatry. METHOD Key advances in quantitative and molecular genetics are noted and findings are summarized with respect to autism, attention-deficit hyperactivity disorder, oppositional defiant and conduct disorders, depression, schizophrenia, and Tourette's syndrome. CONCLUSIONS Genetic findings will be helpful clinically in the elucidation of disordered brain processes, the understanding of nature-nurture interplay, diagnosis, genetic counselling, and pharmacotherapy.
Collapse
Affiliation(s)
- M Rutter
- Medical Research Council Child Psychiatry Unit, Institute of Psychiatry, London, England
| |
Collapse
|
12
|
Abstract
Recent molecular genetic studies of schizophrenia have, until now, been unable to demonstrate any specific major gene for schizophrenia. On the contrary, linkage and association studies have yielded almost exclusively negative or contradictory results. Such studies have involved certain candidate genes, such as the genes for dopamine receptors and other brain neurotransmitters. Some of these candidate genes have now actually been excluded as specific aetiological factors in schizophrenia. Similarly, studies searching for a major gene for susceptibility to schizophrenia involving the whole human genome or large parts of chromosomes have not yielded unambiguously positive results. However, the most recent empirical evidence suggests that many polygenes, acting together, could constitute a risk factor for schizophrenia. It is thus most probable that genetic susceptibility to schizophrenic psychoses is polygenic, and that their effects are dependent on interaction with physical and psychosocial environmental factors.
Collapse
Affiliation(s)
- P Portin
- Department of Biology, University of Turku, Finland
| | | |
Collapse
|
13
|
Arolt V, Lencer R, Nolte A, Müller-Myhsok B, Purmann S, Schürmann M, Leutelt J, Pinnow M, Schwinger E. Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease. AMERICAN JOURNAL OF MEDICAL GENETICS 1996; 67:564-79. [PMID: 8950416 DOI: 10.1002/(sici)1096-8628(19961122)67:6<564::aid-ajmg10>3.0.co;2-r] [Citation(s) in RCA: 135] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
The difficulties in defining the borders of the schizophrenia spectrum is one major source of variance in linkage studies of schizophrenia. The employment of biological markers may prove advantageous. Due to empirical evidence, eye tracking dysfunction (ETD) has been discussed to be the most promising marker for genetic liability to schizophrenia. With respect to the recent progress in genomic scans, which have pointed to the short arm of chromosome 6, we carried out a scan of the 6p21-23 region with 16 microsatellite markers to test for linkage between chromosomal markers and ETD as well as schizophrenia. We tested 5 models of inheritance of ETD and found maximum two-point lod scores of 3.51 for D6S271 and 3.44 for D6S282. By including these markers in a multipoint analysis, a lod score of 4.02 was obtained. In the case of schizophrenia, 7 models were tested; however, with non-significant results. Our findings, together with another recent linkage report, point to the possibility of a second susceptibility locus for schizophrenia which may be located centromeric to the HLA region. Also, the evidence of ETD being a susceptibility marker for schizophrenia receives further support.
Collapse
Affiliation(s)
- V Arolt
- Department of Psychiatry, University of Lübeck School of Medicine, Germany
| | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Serretti A, Macciardi F, Smeraldi E. Identification of symptomatologic patterns common to major psychoses: proposal for a phenotype definition. AMERICAN JOURNAL OF MEDICAL GENETICS 1996; 67:393-400. [PMID: 8837708 DOI: 10.1002/(sici)1096-8628(19960726)67:4<393::aid-ajmg13>3.0.co;2-e] [Citation(s) in RCA: 51] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Our study was designed to identify the underlying symptomatologic structure common to major psychoses as a preliminary step for a phenotype definition. We investigated 1,004 inpatients affected by mood disorders or the schizophrenia spectrum (DSM-III-R) using the OPCRIT checklist (operational criteria checklist for psychotic illness). Symptomatologic structure was extracted by factor analytic techniques and factor scores were first obtained on 500 subjects. A CFA (confirmatory factor analysis) was then conducted on the remaining 504 subjects to evaluate fitness of the model. We identified four factors: excitement, depression, disorganization, and delusion. These factors accounted for 54.6% of the total variance of the OPCRIT checklist symptomatologic subset of 38 items. CFA indices showed a good fit for the model. We identified symptomatologic structures common to major psychoses. The factors identified were confirmed in an independent sample. Two of these symptomatologic structures are partially overlapping with categorical diagnoses (excitement and depression), and two constitute independent psychopathologic traits (delusion and disorganization). The use of "factor-derived scores" in genetic research may add a dimensional definition to the diagnostic subdivision of major psychoses.
Collapse
Affiliation(s)
- A Serretti
- Department of Neuroscience, School of Medicine, Istituto Scientifico H. San Raffaele University of Milan, Italy
| | | | | |
Collapse
|
15
|
Abstract
Research prospects and priorities in the field of autism are discussed with respect to (a) diagnosis, classification, and epidemiology; (b) clinical research; (c) neuropsychological research; (d) genetics; (e) structural and functional brain imaging; (f) postmortem studies; (g) other biological research; and (h) treatment research. Also, it is argued that research into autism has a priority in the broader field of developmental psychopathology because it carries the promise of throwing light on casual mechanisms that apply beyond the syndrome of autism.
Collapse
Affiliation(s)
- M Rutter
- Institute of Psychiatry, Denmark Hill, London, England
| |
Collapse
|
16
|
Simonoff E, Bolton P, Rutter M. Mental retardation: genetic findings, clinical implications and research agenda. J Child Psychol Psychiatry 1996; 37:259-80. [PMID: 8707910 DOI: 10.1111/j.1469-7610.1996.tb01404.x] [Citation(s) in RCA: 43] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
The most important genetic advances in the field of mental retardation include the discovery of the novel genetic mechanism responsible for the Fragile X syndrome, and the imprinting involved in the Prader-Willi and Angelman syndromes, but there have also been advances in our understanding of the pathogenesis of Down syndrome and phenylketonuria. Genetic defects (both single gene Mendelizing disorders and cytogenetic abnormalities) are involved in a substantial proportion of cases of mild as well as severe mental retardation, indicating that the previous equating of severe mental retardation with pathology, and of mild retardation with normal variation, is a misleading over-simplication. Within the group in which no pathological cause can be detected, behaviour genetic studies indicate that genetic influences are important, but that their interplay with environmental factors, which are also important, is at present poorly understood. Research into the joint action of genetic and environmental influences in this group will be an important research area in the future.
Collapse
Affiliation(s)
- E Simonoff
- MRC Child Psychiatry Unit and Centre for Social, Genetic and Developmental Psychiatry, Institute of Psychiatry, London, U.K
| | | | | |
Collapse
|
17
|
Bailey A, Phillips W, Rutter M. Autism: towards an integration of clinical, genetic, neuropsychological, and neurobiological perspectives. J Child Psychol Psychiatry 1996; 37:89-126. [PMID: 8655659 DOI: 10.1111/j.1469-7610.1996.tb01381.x] [Citation(s) in RCA: 369] [Impact Index Per Article: 13.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
Autism constitutes one of the best validated child psychiatric disorders. Empirical research has succeeded in delineating the key clinical phenomena, in demonstrating strong genetic influences on the underlying liability, and in identifying basic cognitive deficits. A range of neurobiological abnormalities has also been found, although the replicability of specific findings has not been high. An understanding of the causal processes leading to autism, and accounting for the marked variability in its manifestations, requires an integration across these different levels of enquiry. Although this is not yet possible, a partial integration provides a useful strategy for identifying key research questions, the limitations of existing hypotheses, and future research directions that are likely to prove fruitful. The research findings for each research level are critically reviewed in order to consider how to move towards an integration across levels.
Collapse
Affiliation(s)
- A Bailey
- MRC Child Psychiatry Unit, Institute of Psychiatry, London, U.K
| | | | | |
Collapse
|
18
|
Arolt V, Lencer R, Nolte A, Pinnow M, Schwinger E. Eye tracking dysfunction in families with multiple cases of schizophrenia. Eur Arch Psychiatry Clin Neurosci 1996; 246:175-81. [PMID: 8832194 DOI: 10.1007/bf02188950] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
There is increasing evidence that the genetic predisposition for schizophrenia in families affects more individuals than those fulfilling the criteria for schizophrenia. This finding is supposed to be one of the major problems in molecular genetic schizophrenia research, especially when linkage studies are employed. Eye-tracking dysfunction (ETD), which is conceived as a possible phenotypic marker for genetic liability to schizophrenia, may offer considerable advantages. However, there is only little information from families with multiple occurrence of schizophrenia. It is still unclear whether in these families ETD aggregates with diagnoses from the schizophrenia spectrum. This first report from an ongoing study presents the results of 48 individuals from 6 multiplex families. Smooth-pursuit eye movements were recorded by infrared reflectometry and assessed by quantitative measurement techniques. Along with the high degree of psychiatric morbidity in these families, in 56.3% of the individuals ETD was assessed. Reduced mean pursuit gain was present in 39.6%. The distribution of eye-tracking dysfunction resembles the distribution of schizophrenia-related psychiatry morbidity.
Collapse
Affiliation(s)
- V Arolt
- Department of Psychiatry, University of Lübeck School of Medicine, Germany
| | | | | | | | | |
Collapse
|
19
|
Abstract
Despite initial setbacks, linkage studies with DNA markers continue to occupy center stage in psychiatric research. Advances in molecular and statistical techniques have revived the search for disease genes, leading to a new harvest of findings. Most interest in recent years has focused on potential linkages between schizophrenia and chromosomes X-Y (the pseudoautosomal region) and 22q12-13.1, and between bipolar affective disorder and chromosomes 18 (pericentromeric region) and 21q22.3. This article provides a critical evaluation of theses studies, with implications for future research. Concerns over earlier linkage trials make this scrutiny current and topical.
Collapse
Affiliation(s)
- M Baron
- Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
| |
Collapse
|
20
|
Wang S, Sun CE, Walczak CA, Ziegle JS, Kipps BR, Goldin LR, Diehl SR. Evidence for a susceptibility locus for schizophrenia on chromosome 6pter-p22. Nat Genet 1995; 10:41-6. [PMID: 7647789 DOI: 10.1038/ng0595-41] [Citation(s) in RCA: 194] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
We have performed linkage analysis in 186 multiplex families to search for genes that predispose to schizophrenia. Under a model with partially dominant inheritance, moderately broad disease definition and assuming locus homogeneity, a lod score of 3.2 was obtained for D6S260 on chromosome 6p23. A multipoint lod score of 3.9 (P = 2.3 x 10(-5)) was achieved when the F13A1 and D6S260 loci were analysed, allowing for locus heterogeneity. Adjusted for testing of multiple models, the multipoint lod score of 3.9 under heterogeneity has a genome wide significance of between 5-8%. The nonparametric affected pedigree member test provided results (P = 3 x 10(-4)) also supporting this finding. Our findings provide supportive evidence for a susceptibility locus for schizophrenia on distal chromosome 6p, and support a model of locus heterogeneity.
Collapse
Affiliation(s)
- S Wang
- Molecular Epidemiology and Disease Indicators Branch, NIDR, Bethesda, Maryland 20892, USA
| | | | | | | | | | | | | |
Collapse
|